It follows that if such APOBEC3A-expressing tumour cells were to acquire mutations that caused them to become more proliferative (as might be expected if the subclone were to expand to constitute a significant portion of the tumour), this would result in loss of APOBEC3A expression (and potentially an increase in APOBEC3B expression). This evidence concerns the gene APOBEC3B and neoplasm.